Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

McGill University

$101,250.00

Investigating the role of the immune system in the pathology of Peutz-Jeghers syndrome (PJS)

EF 2014-15

Résumé
Peutz Jeghers syndrome (PJS) is a disease characterized by gastrointestinal (GI) polyps and a 93% cumulative risk of cancer development by the age of 65. PJS is due to mutations in the protein LKB1 resulting in decreased expression of this protein. LKB1 is a multi-faceted protein with roles in cellular proliferation, cell polarity and cellular metabolism. Mice heterozygous for LKB1 express decreased levels of this protein and develop GI polyps similar to those found in PJS patients and develop cancers in the liver, bone and uterus. While decreased LKB1 expression has clearly been implicated in disease development, the mechanism by which decreased LKB1 expression drives GI polyp and cancer development has not yet been fully elucidated. Our preliminary investigation has indicated that immune dysfunction may be driving PJS development. A recent publication from our laboratory has demonstrated that T cell specific deletion of LKB1 results in increased activation of these immune cells. Further investigation revealed that heterozygous expression of LKB1 in T cells also resulted in activated T cells and, unexpectedly, aged mice developed PJS-like disease. The proposed research will explore the role of immune cells in PJS disease development and their mechanism(s) of action. As immune dysfunction has not been previously associated with PJS, this research is novel and has the potential to provide targeted immunotherapeutic options for PJS patients. Currently, there are no treatments available for PJS patients. Patients are largely monitored for cancer development and polyps are excised bi-annually. Additionally, a causative link between chronic inflammation and tumor development has been observed in many cancer models. As our preliminary findings suggest that PJS may be another such disease, identification of LKB1 as a regulator of inflammation-induced cancer development could indicate a role for metabolic regulatory genes in other inflammation-associated cancers.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
318732
Name
Poffenberger Maya C
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Investigating the role of the immune system in the pathology of Peutz-Jeghers syndrome (PJS)
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$101,250
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cytokine; Gastrointestinal; Immunology; Inflammation; Lkb1; Metabolism; Mouse Model; Oncology; Peutz-Jeghers Syndrome; T Cell
Abstract
Peutz Jeghers syndrome (PJS) is a disease characterized by gastrointestinal (GI) polyps and a 93% cumulative risk of cancer development by the age of 65. PJS is due to mutations in the protein LKB1 resulting in decreased expression of this protein. LKB1 is a multi-faceted protein with roles in cellular proliferation, cell polarity and cellular metabolism. Mice heterozygous for LKB1 express decreased levels of this protein and develop GI polyps similar to those found in PJS patients and develop cancers in the liver, bone and uterus. While decreased LKB1 expression has clearly been implicated in disease development, the mechanism by which decreased LKB1 expression drives GI polyp and cancer development has not yet been fully elucidated. Our preliminary investigation has indicated that immune dysfunction may be driving PJS development. A recent publication from our laboratory has demonstrated that T cell specific deletion of LKB1 results in increased activation of these immune cells. Further investigation revealed that heterozygous expression of LKB1 in T cells also resulted in activated T cells and, unexpectedly, aged mice developed PJS-like disease. The proposed research will explore the role of immune cells in PJS disease development and their mechanism(s) of action. As immune dysfunction has not been previously associated with PJS, this research is novel and has the potential to provide targeted immunotherapeutic options for PJS patients. Currently, there are no treatments available for PJS patients. Patients are largely monitored for cancer development and polyps are excised bi-annually. Additionally, a causative link between chronic inflammation and tumor development has been observed in many cancer models. As our preliminary findings suggest that PJS may be another such disease, identification of LKB1 as a regulator of inflammation-induced cancer development could indicate a role for metabolic regulatory genes in other inflammation-associated cancers.
Competitiondate
201411
Approvedterm2
2 yrs 3 mths
Pinamesdelim
Poffenberger, Maya C
Approvedterm
2 ans 3 mois
Cihrcontribution2
~ $101,250~ $0~